A widely used cholesterol lowering medicine could be effective in significantly easing symptoms of  COVID-19, downgrading its danger-level to that of a common cold, a Hebrew University scientist says. Prof. Yaakov Nahmias, director of the Alexander Grass Center for Bioengineering at the Hebrew University of Jerusalem, in collaboration with Dr. Benjamin tenOever of New York's Mount Sinai Medical Center, found that the drug Fenofibrate could inhibit Covid-19's ability to reproduce in lung cells. In the  researchers' lab study, whose findings appear this week in Cell Press' Sneak Peek, the drug was found to be effective in treating infected human tissue. Clinical studies are due to get underway.  Nahmias told KAN's Naomi Segal how the researchers arrived at the idea that a cholesterol-lowering drug could help in the treatment of coronavirus.